| Authors: |
Fuchs JD; San Francisco Department of Public Health, California ; University of California , San Francisco., Frank I; University of Pennsylvania , Philadelphia., Elizaga ML; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center., Allen M; Division of AIDS, National Institutes of Allergy and Infectious Diseases , Bethesda, Maryland., Frahm N; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center., Kochar N; Statistical Center for HIV/AIDS Research and Prevention , Fred Hutchinson Cancer Research Center , Seattle, Washington., Li S; Statistical Center for HIV/AIDS Research and Prevention , Fred Hutchinson Cancer Research Center , Seattle, Washington., Edupuganti S; Emory University , Atlanta, Georgia., Kalams SA; Vanderbilt University , Nashville, Tennessee., Tomaras GD; Duke Human Vaccine Institute, Duke University Medical Center , Durham, North Carolina., Sheets R; Division of AIDS, National Institutes of Allergy and Infectious Diseases , Bethesda, Maryland., Pensiero M; Division of AIDS, National Institutes of Allergy and Infectious Diseases , Bethesda, Maryland., Tremblay MA; Profectus Biosciences, Inc. , Tarrytown, New York., Higgins TJ; Profectus Biosciences, Inc. , Tarrytown, New York., Latham T; Profectus Biosciences, Inc. , Tarrytown, New York., Egan MA; Profectus Biosciences, Inc. , Tarrytown, New York., Clarke DK; Profectus Biosciences, Inc. , Tarrytown, New York., Eldridge JH; Profectus Biosciences, Inc. , Tarrytown, New York., Mulligan M, Rouphael N, Estep S, Rybczyk K, Dunbar D, Buchbinder S, Wagner T, Isbell R, Chinnell V, Bae J, Escamilla G, Tseng J, Fair R, Ramirez S, Broder G, Briesemeister L, Ferrara A |
